AI English summary of an SEC filing — figures as filed
PTC PTCPTC said ARR grew 14% (12% in constant currency) to $2.25 billion as of the end of FY'23 from FY'24, and that revenue grew 10% (9% in constant currency) in FY'23 compared with FY'24.
Key points
AI summaryPTC said ARR grew 14% (12% in constant currency) to $2.25 billion as of the end of FY'23 from FY'24, and that revenue grew 10% (9% in constant currency) in FY'23 compared with FY'24.
The company said operating cash flow for FY'24 rose 23% from FY'23 to $750 million, and free cash flow rose 25% to $736 million. It cited growth in top-line revenue from its subscription business model and operational discipline as the drivers of the increase.
PTC said cash used in financing activities in FY'24 included $620.0 million paid to settle the deferred acquisition payment for ServiceMax, $739.8 million of Q1 borrowings in FY'24 to fund that payment and the pure-systems acquisition, and subsequent net debt payments of $693.9 million.
The company said its effective tax rate for FY'24 was lower than in FY'23. It said it recorded a benefit of $14.4 million for additional foreign tax credits from the Varian Medical Systems ruling, which was offset by tax expense of $4.6 million related to a tax reserve in a foreign jurisdiction.
Key figures
Fiscal year ended September 30, 2024
- Revenue
- $2.3B
- Operating income
- $588M
- Net income
- $376M
- EPS
- $3.12
- Gross profit
- $1.9B
- Operating cash flow
- $750M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
ARR and Revenue Growth
PTC said ARR grew 14% (12% in constant currency) to $2.25 billion as of the end of FY'23 from FY'24, and that revenue grew 10% (9% in constant currency) in FY'23 compared with FY'24.
Source · Based on the MD&A text of the filing
Operating and Free Cash Flow
The company said operating cash flow for FY'24 rose 23% from FY'23 to $750 million, and free cash flow rose 25% to $736 million. It cited growth in top-line revenue from its subscription business model and operational discipline as the drivers of the increase.
Source · Based on the MD&A text of the filing
ServiceMax Deferred Acquisition Payment and Borrowing Activity
PTC said cash used in financing activities in FY'24 included $620.0 million paid to settle the deferred acquisition payment for ServiceMax, $739.8 million of Q1 borrowings in FY'24 to fund that payment and the pure-systems acquisition, and subsequent net debt payments of $693.9 million.
Source · Based on the MD&A text of the filing
Effective Tax Rate and Tax Items
The company said its effective tax rate for FY'24 was lower than in FY'23. It said it recorded a benefit of $14.4 million for additional foreign tax credits from the Varian Medical Systems ruling, which was offset by tax expense of $4.6 million related to a tax reserve in a foreign jurisdiction.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…